Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 114747-44-3 | MDL No. : | MFCD00329019 |
Formula : | C30H27N3O | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | PITZBBWQUBGWTD-UHFFFAOYSA-N |
M.W : | 445.55 | Pubchem ID : | 3104873 |
Synonyms : |
|
Num. heavy atoms : | 34 |
Num. arom. heavy atoms : | 22 |
Fraction Csp3 : | 0.23 |
Num. rotatable bonds : | 1 |
Num. H-bond acceptors : | 2.0 |
Num. H-bond donors : | 0.0 |
Molar Refractivity : | 150.14 |
TPSA : | 28.07 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | Yes |
CYP2C19 inhibitor : | Yes |
CYP2C9 inhibitor : | Yes |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -4.2 cm/s |
Log Po/w (iLOGP) : | 4.33 |
Log Po/w (XLOGP3) : | 6.78 |
Log Po/w (WLOGP) : | 5.61 |
Log Po/w (MLOGP) : | 5.06 |
Log Po/w (SILICOS-IT) : | 5.88 |
Consensus Log Po/w : | 5.53 |
Lipinski : | 1.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -7.29 |
Solubility : | 0.000023 mg/ml ; 0.0000000517 mol/l |
Class : | Poorly soluble |
Log S (Ali) : | -7.18 |
Solubility : | 0.0000297 mg/ml ; 0.0000000666 mol/l |
Class : | Poorly soluble |
Log S (SILICOS-IT) : | -9.73 |
Solubility : | 0.0000000835 mg/ml ; 0.0000000002 mol/l |
Class : | Poorly soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 2.0 |
Synthetic accessibility : | 5.31 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P280-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
[ 114747-45-4 ]
1,3,3-Trimethyl-6'-(piperidin-1-yl)spiro[indoline-2,3'-naphtho[2,1-b][1,4]oxazine]
Similarity: 0.99
[ 27333-47-7 ]
1,3,3-Trimethylspiro[indoline-2,3'-naphtho[2,1-b][1,4]oxazine]
Similarity: 0.99
[ 114747-48-7 ]
1,3,3-Trimethyl-6'-morpholinospiro[indoline-2,3'-naphtho[2,1-b][1,4]oxazine]
Similarity: 0.98
[ 27333-50-2 ]
5-Chloro-1,3,3-trimethylspiro[indoline-2,3'-naphtho[2,1-b][1,4]oxazine]
Similarity: 0.90
[ 1498-88-0 ]
1',3',3'-Trimethyl-6-nitrospiro[chromene-2,2'-indoline]
Similarity: 0.65